Law360 reports on Life Spine settlement

In an October 24, 2019 Law360 article, Seeger Weiss founding partner Stephen Weiss spoke about his work representing former employees of Life Spine Inc., a medical device maker accused of paying surgeons to use and promote their products. The article reads, in part: Life Spine Inc. and two executives have agreed to pay nearly $6 […]

October 25, 2019

commercial litigation

In an October 24, 2019 Law360 article, Seeger Weiss founding partner Stephen Weiss spoke about his work representing former employees of Life Spine Inc., a medical device maker accused of paying surgeons to use and promote their products.

The article reads, in part:

Life Spine Inc. and two executives have agreed to pay nearly $6 million total to settle the federal government’s False Claims Act suit accusing the medical device maker and the executives of paying surgeons to use and promote their products.

In a series of filings Wednesday, the government told a New York federal judge it has reached settlements with Life Spine, CEO Michael Butler and Vice President Richard Greiber totaling about $5.99 million to resolve the government’s claims against them. Life Spine will shoulder the lion’s share of the payout — $5.5 million — while Butler will cough up $375,000 plus interest and Greiber will have to pay $115,000, according to the government.

Stephen A. Weiss of Seeger Weiss LLP, an attorney for the former Life Spine employees, told Law360 on Thursday that his clients still have individual retaliation claims that will move forward.

“It was a very positive outcome and I’m pleased the parties came together in the manner they did,” he said. “This was an ability to pay settlement, meaning that the defendants had limited funds with which to settle the claims. Under those circumstances the government did an outstanding job in resolving the claims at the amounts that they did.”

The former Life Spine employees, through relator BNHT LLC, are represented by Stephen A. Weiss and Christopher L. Ayers of Seeger Weiss LLP.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More